Tech Company Financing Transactions
Transverse Medical Funding Round
Private investors joined a $10 million Series B funding round for Transverse Medical. The round was announced on 4/29/2025.
Transaction Overview
Company Name
Announced On
4/29/2025
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to expand operational infrastructure and grow its engineering, regulatory, and operating teams.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2650 East 40th Avenue
Denver, CO 80205
USA
Denver, CO 80205
USA
Phone
Undisclosed
Website
Email Address
Overview
Transverse Medical Inc. is a medical device company developing the POINT-GUARD� Cerebral Embolic Protection device to address the unmet need for Full-Brain protection and eliminate the clinical problem of periprocedural Stroke and Silent Stroke in Structural Heart Procedures, such as Transcatheter Aortic Valve Replacement (TAVR).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Goslau
Chief Financial Officer
Chad Frederickson
Chief Medical Officer
Dennis Donohoe
Browse more venture capital transactions:
Prev: 4/29/2025: Forge Nano venture capital transaction
Next: 4/29/2025: 1NCE venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs